GLP-1 Before & After Guide
GLP-1 before and after: realistic results, by the numbers
~15–20%
average loss by 60–72 weeks
12+ mo
how long a real transformation takes
Wide
the spread photos never show
Everyone searching GLP-1 before and after wants the same thing: proof it works and a sense of what to expect. Here is the honest version, built from trial data instead of the most dramatic photo on the internet. Average weight loss runs roughly 8% on liraglutide, 15% on semaglutide, and 20% on tirzepatide over a year-plus of treatment, with an enormous spread around every average. The striking photos are real but selected from the top of that spread, taken after 12 or more months, and they hide the timeline, the plateaus, and the person's starting point. This guide gives you the numbers, the calendar, and a way to document your own before-and-after that is worth more than any stranger's.
Highlights
Key takeaways
- 01
The head-to-head averages, over 60 to 72 weeks: liraglutide ~8%, semaglutide 2.4 ~15%, tirzepatide ~20% of body weight. Newer combinations report low twenties.
- 02
A real transformation takes a year or more: titration is slow, the middle months are fastest, and the curve flattens near month twelve.
- 03
Photos mislead by selection and compression: they show top-of-range responders, after long durations, without the plateaus or the starting weight that shaped them.
- 04
The spread is the untold story: on the same drug and dose, some people lose over 25% and some under 5%. Your number depends on dose reached, adherence, protein, and training.
- 05
Non-scale wins are the underrated before-and-after: blood pressure, glucose, joint pain, sleep, food noise, and clothing all change on their own timelines.
- 06
Your honest before-and-after is a dataset, not a highlight reel: consistent weigh-ins, measurements, photos, and strength checks beat a single flattering angle.
What before-and-after actually looks like, by drug
| Medication | Avg loss (trial) | Duration | For a 220 lb start |
|---|---|---|---|
| Liraglutide (Saxenda) | ~8% | 56 weeks | ~18 lb |
| Semaglutide (Wegovy) | ~15% | 68 weeks | ~33 lb |
| Tirzepatide (Zepbound) | ~20% | 72 weeks | ~44 lb |
| Oral semaglutide (Rybelsus) | Below injectable sema | 68 weeks | varies by dose |
| Diabetes-dose versions | Several points lower | varies | smaller average |
| Any drug: individual spread | <5% to >25% | same period | the range photos hide |
Trial-average figures at labeled doses; real-world results vary with dose reached, adherence, and habits. Pounds are illustrative from a 220 lb starting weight. Diabetes-population trials run lower than obesity trials.
The real numbers by drug
Across the pivotal obesity trials, average weight loss lands around 8% for liraglutide, 15% for semaglutide 2.4 mg, and 20% for tirzepatide over roughly a year to 72 weeks, with the newest combinations reporting the low twenties. In pounds from a 220 lb start, that is roughly 18, 33, and 44 pounds respectively, as averages, at trial durations.
Those averages are the honest anchor. The dramatic 100-pound transformations exist, but they belong to people who started much heavier, responded above average, and stayed the course for well over a year. Our how-much-you-can-lose guide breaks down the spread; the point here is that a realistic personal target is your drug's average, adjusted for your starting point and habits.
The timeline a photo never shows
A before-and-after photo is two frozen moments. The reality between them is a slow curve. The first weeks on a starter dose barely move the scale, because those doses build tolerance rather than drive loss. The middle months, once you reach a therapeutic dose, are where steady visible change happens. Then, usually around the one-year mark, the curve flattens into maintenance as a smaller body needs fewer calories.
So the honest calendar for a real transformation is twelve months or more, with plateaus along the way that are normal and not failure (our plateau guide covers reading them). Anyone promising a dramatic before-and-after in six weeks is selling the starter-dose illusion.
Why before-and-after photos mislead
Selection: the photos that circulate are the top of the response distribution, because those are the ones people post. For every dramatic result there are quieter ones that never make it online.
Compression: two images erase the timeline, the dose changes, the rough side-effect weeks, and the plateaus, making a year of uneven work look like a switch that flipped. Add lighting, posture, and clothing, and a photo becomes a poor instrument for setting your expectations. The numbers above are a better mirror.
The non-scale before-and-after
The transformation that matters most rarely photographs. Within months, many people see blood pressure fall (5 to 6 mmHg systolic on average), glucose and A1c improve, triglycerides drop, joint pain ease, sleep and energy lift, and the constant food noise go quiet. Clothing size and waist measurement often change faster than the scale, because fat and water shift before the number does.
These are the before-and-afters worth tracking, and they arrive on their own schedules. Judging your progress only by the scale, or only by the mirror, misses most of what the medication is actually doing.
How to document your own before-and-after honestly
A useful personal before-and-after is a dataset, not a single flattering angle. The elements that make it honest and motivating:
- A true baseline on day one: weight, waist and hip measurements, a photo in consistent lighting and pose, and how you feel.
- A weekly weight trend, judged as a line rather than daily verdicts.
- Monthly measurements and photos: the tape measure catches recomposition the scale hides.
- Strength checks: holding or gaining strength means the loss is quality loss, not muscle.
- One-line notes on the non-scale wins: sleep, energy, food noise, joints, clothing.
- Dose and side-effect context, so your future self can read the story, not just the endpoints.
When results aren't coming
If your own before-and-after is stalling, the fix is usually findable before it is fundamental: confirm you have reached a therapeutic dose, log a truly honest week, and check protein and steps. Our not-losing-weight checklist walks the order.
Genuine limited response (under about 5% at a full dose after three months, with clean adherence) is real for a minority and is a prescriber conversation, not a verdict: switching molecules is routine. Bring your documented data, which is exactly what makes that conversation productive.
Bring to your prescriber if
- Under ~5% loss after 3 months at a full therapeutic dose with clean adherence
- Weight dropping so fast it worries you (pace is adjustable)
- Loss with clearly falling strength (quality-of-loss problem)
- Comparing yourself to photos is harming your mood or driving extreme restriction
- Rapid loss with significant loose skin or facial change that distresses you
- Any plateau past 4 weeks you cannot explain with an honest audit
FAQ
Frequently asked questions
What is a realistic GLP-1 before and after?
By trial averages over a year-plus: about 8% of body weight on liraglutide, 15% on semaglutide, and 20% on tirzepatide, with a wide individual spread. Dramatic photos come from top-of-range responders after 12+ months and hide the timeline and starting point.
How long before you see before-and-after results on a GLP-1?
Little in the first weeks (starter doses build tolerance), steady visible change through the middle months once at a therapeutic dose, flattening near month twelve. A real transformation is a year or more, with normal plateaus along the way.
Which GLP-1 has the best before and after?
On averages, tirzepatide (~20%) leads semaglutide (~15%) and liraglutide (~8%), but individual spread is huge and access, tolerability, and adherence decide real outcomes. Your own consistent tracking predicts your result better than any photo.
Why do my results look different from the before-and-after photos?
Photos are selected from the top of the response range, taken after long durations, and compressed to hide plateaus and starting weight. The averages and your own trend line are honest mirrors; a single stranger's photo is not.
Track your GLP-1 journey on one quiet line.
Log your shot, injection site, meals, and side-effect severity together, and walk into your next appointment with a week-by-week picture instead of a guess.
Sources
- 1.Pivotal obesity trials: STEP (semaglutide), SURMOUNT (tirzepatide), SCALE (liraglutide) average weight-loss outcomes. Find on PubMed ↗
- 2.SELECT and cardiometabolic secondary endpoints: blood pressure, lipids, and glucose changes on treatment. Read on NEJM ↗
- 3.Body-composition and measurement literature on recomposition versus scale weight during weight loss. Find on PubMed ↗
This guide is for general education and is not medical advice. It doesn't account for your personal medical history, other medications, or your individual situation, and it doesn't replace a conversation with your doctor or pharmacist. Do not start, stop, or change the dose of GLP-1 or any medication based on what you read here. If you think you have a medical emergency, call your local emergency number. DoseLog is a tracking app; drug and company names are used factually under nominative fair use, and DoseLog is not affiliated with, endorsed by, or sponsored by any manufacturer mentioned.
Keep reading
Zepbound for Sleep Apnea
Zepbound for sleep apnea: what SURMOUNT-OSA actually showed
GLP-1 & Heart Health Guide
GLP-1s and your heart: what the outcome trials actually proved
Ozempic Face Guide
Ozempic face: why it happens, whether it lasts, and how to soften it
GLP-1 Plateau Guide
GLP-1 plateau: why the scale stalls and what actually helps